A case of successful surgical treatment of type 2 diabetes mellitus in an obese patient in bariatric practice
https://doi.org/10.24884/0042-4625-2024-183-4-60-63
Abstract
The relevance of the problem of obesity is due to the progressive increase in morbidity worldwide and the high risk of developing pathological conditions associated with overweight. The development of cardiovascular diseases, lipid metabolism disorders, and type 2 diabetes mellitus is of the greatest importance. Among the various types of treatment for morbid obesity, bariatric surgery occupies a leading position and acquires a special role in the correction of type 2 diabetes mellitus associated with excess body weight due to its greatest metabolic efficiency. A clinical case of surgical treatment of type 2 diabetes mellitus associated with obesity in a middle-aged woman with unsatisfactory glycemic control on insulin therapy is presented. Gastric bypass was performed. The early postoperative period is smooth. Four years later, the body mass index was 24.9 kg/m2, the target levels of glycemia and glycated hemoglobin were achieved in the complete absence of insulin therapy.
About the Authors
S. G. Balandov
Pavlov University
Russian Federation
Competing Interests:
Russian Federation
Balandov Stanislav G., Cand. of Sci. (Med.), Head of the Surgical Department № 2
6-8, L’va Tolstogo str., Saint Petersburg, 197022
Competing Interests:
The authors declare no conflict of interest.
D. I. Vasilevsky
Pavlov University
Russian Federation
Competing Interests:
Russian Federation
Vasilevsky Dmitry I., Dr. of Sci. (Med.), Professor, Head of the Department of Surgical Diseases of the Faculty of Dentistry named after Prof. A. M. Ganichkin
6-8, L’va Tolstogo str., Saint Petersburg, 197022
Competing Interests:
The authors declare no conflict of interest.
K. A. Anisimova
Pavlov University
Russian Federation
Competing Interests:
Russian Federation
Anisimova Kristina A., Cand. of Sci. (Med.), Surgeon of the Surgical Department № 2,
6-8, L’va Tolstogo str., Saint Petersburg, 197022
Competing Interests:
The authors declare no conflict of interest.
G. V. Semikova
Pavlov University
Competing Interests:
Semikova Galina V., Cand. of Sci. (Med.), Assistant of the Department of Faculty Therapy with the Course of Endocrinology, Cardiology and Functional Diagnostics with the G. F. Lang Clinic
6-8, L’va Tolstogo str., Saint Petersburg, 197022
Competing Interests:
The authors declare no conflict of interest.
Z. M. Hamid
Pavlov University
Russian Federation
Competing Interests:
Russian Federation
Hamid Zarina M., Cand. of Sci. (Med.), Surgeon of the Surgical Department № 2
6-8, L’va Tolstogo str., Saint Petersburg, 197022
Competing Interests:
The authors declare no conflict of interest.
E. T. Berulava
Pavlov University
Russian Federation
Competing Interests:
Russian Federation
Berulava Elena T., Surgeon of the Surgical Department № 2
6-8, L’va Tolstogo str., Saint Petersburg, 197022
Competing Interests:
The authors declare no conflict of interest.
References
1. Dedov I. I., Shestakova M. V., Melnichenko G. A. et al. Interdisciplinary Clinical Guidelines for the Treatment of Obesity and Comorbid Diseases. Obesity and Metabolism. 2021;18(1):5–99. (In Russ.).
2. Eisenberg D., Shikora S. A., Aarts E. et al. 2022 American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO): Indications for metabolic and bariatric surgery. J. Surgery for Obesity and Related Diseases. 2022;18(12):1345–1356.
3. Balandov S. G., Vasilevsky D. I., Anisimova K. A. et al. Principles of bariatric intervention selection (literature review). The Scientific Notes of Pavlov University. 2018;XXV(2):69–74. (In Russ.).
4. Sedletskiy Yu. I., Salukhov V. V., Vasilevskiy D. I. Obesity and associated diseases. Conservative and surgical treatment. Guide for doctors / eds by S. F. Bagnenko, E. V. Kryukov, F. Bagnenko, E. V. Kryukov. SPb: Spetslit. 2022. 493 p. (In Russ.).
5. Salehi M., Peterson R., Tripathy D. et al. Insulinotropic effect of endogenous incretins is greater after gastric bypass than sleeve gastrectomy despite diminished beta-cell sensitivity to plasma incretins. MedRxiv [Preprint]. 2023:2023.03.28.23287755.
6. Min T., Prior S. L., Churm R. et al. Effect of laparoscopic sleeve gastrectomy on static and dynamic measures of glucose homeostasis and incretin hormone response 4-years post-operatively. Obes. Surg. 2020;30(1):46–55.
7. Mozgunova V. S., Semikova G. V., Volkova A. R. et al. Role of glucagon-like peptide 1 in remission of type 2 diabetes mellitus in obese patients after metabolic surgery. Endocrinology: news, opinion, training. 2023;12(4):28–34. (In Russ.).
8. Larraufie P., Roberts G. P., McGavigan A. K. et al. Important role of the GLP-1axis for glucose homeostasis after bariatric surgery. Cell Rep. 2019;26:1399–1408.
9. Sandoval D. A., Patti M. E. Glucose metabolism after bariatric surgery: implications for T2DM remission and hypoglycaemia. Nat. Rev. Endocrinol. 2023;19(3):164–176.
10. Kornyushin O. V., Sakeyan I. S., Kravchuk E. N. et al. Predicting remission of type 2 diabetes mellitus after bariatric surgery. Diabetes mellitus. 2021;E 24(6):565–570. (In Russ.).
11.
Supplementary files
Review
For citations:
Balandov S.G., Vasilevsky D.I., Anisimova K.A., Semikova G.V., Hamid Z.M., Berulava E.T. A case of successful surgical treatment of type 2 diabetes mellitus in an obese patient in bariatric practice. Grekov's Bulletin of Surgery. 2024;183(4):60-63. (In Russ.) https://doi.org/10.24884/0042-4625-2024-183-4-60-63
Views:
212
Email this article 